CoChat

Shared genetic background between children and adults with attention deficit/hyperactivity disorder

Open access
Rovira, Paula, Demontis, Ditte, Sánchez-Mora, Cristina, Zayats, Tetyana, Klein, Marieke, Mota, Nina Roth, Weber, Heike, Garcia-Martínez, Iris, Pagerols, Mireia, Vilar-Ribó, Laura, Arribas, Lorena, Richarte, Vanesa, Corrales, Montserrat, Fadeuilhe, Christian, Bosch, Rosa, Martin, Gemma Español, Almos, Peter, Doyle, Alysa E., Grevet, Eugenio Horacio, Grimm, Oliver, Halmøy, Anne, Hoogman, Martine, Hutz, Mara, Jacob, Christian P., Kittel-Schneider, Sarah, Knappskog, Per M., Lundervold, Astri J., Rivero, Olga, Rovaris, Diego Luiz, Salatino-Oliveira, Angelica, da Silva, Bruna Santos, Svirin, Evgeniy, Sprooten, Emma, Strekalova, Tatyana, ADHD Working Group of the Psychiatric Genomics Consortium, 23andMe Research team, Arias-Vasquez, Alejandro, Sonuga-Barke, Edmund J. S., Asherson, Philip, Bau, Claiton Henrique Dotto, Buitelaar, Jan K., Cormand, Bru, Faraone, Stephen V., Haavik, Jan, Johansson, Stefan E., Kuntsi, Jonna, Larsson, Henrik, Lesch, Klaus-Peter, Reif, Andreas, Rohde, Luis Augusto, Casas, Miquel, Børglum, Anders D., Franke, Barbara, Ramos-Quiroga, Josep Antoni, Soler Artigas, María, Ribasés, Marta · 2020 · Neuropsychopharmacology

Published version of a preprint

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Abstract

Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by age-inappropriate symptoms of inattention, impulsivity, and hyperactivity that persist into adulthood in the majority of the diagnosed children. Despite several risk factors during childhood predicting the persistence of ADHD symptoms into adulthood, the genetic architecture underlying the trajectory of ADHD over time is still unclear. We set out to study the contribution of common genetic variants to the risk for ADHD across the lifespan by conducting meta-analyses of genome-wide association studies on persistent ADHD in adults and ADHD in childhood separately and jointly, and by comparing the genetic background between them in a total sample of 17,149 cases and 32,411 controls. Our results show nine new independent loci and support a shared contribution of common genetic variants to ADHD in children and adults. No subgroup heterogeneity was observed among children, while this group consists of future remitting and persistent individuals. We report similar patterns of genetic correlation of ADHD with other ADHD-related datasets and different traits and disorders among adults, children, and when combining both groups. These findings confirm that persistent ADHD in adults is a neurodevelopmental disorder and extend the existing hypothesis of a shared genetic architecture underlying ADHD and different traits to a lifespan perspective.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41386-020-0664-5

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Manhattan plots of the three GWAS meta-analyses conducted. (a) GWAS-MA of nine cohorts of persistent ADHD in adults, (b) GWAS-MA of ten cohorts of ADHD in childhood, and (c) GWAS-MA of all datasets of ADHD across the lifespan (ADHD in childhood + persistent ADHD). Horizontal lines indicate suggestive (P value = 5.00E−06) and genome-wide significant (P = 5.00E−08) thresholds in a-b, and c, respectively.
Fig. 1 Manhattan plots of the three GWAS meta-analyses conducted. (a) GWAS-MA of nine cohorts of persistent ADHD in adults, (b) GWAS-MA of ten cohorts of ADHD in childhood, and (c) GWAS-MA of all datasets of ADHD across the lifespan (ADHD in childhood + persistent ADHD). Horizontal lines indicate suggestive (P value = 5.00E−06) and genome-wide significant (P = 5.00E−08) thresholds in a-b, and c, respectively.CC BY · PubMed Central
Fig. 2 Polygenic risk scores for ADHD in childhood tested on persistent ADHD as target sample. a Bar plot and b quintile plot of meta-analysis odds ratios (OR meta) with 95% confidence intervals for P value threshold = 0.4 using the third quintile as baseline.
Fig. 2 Polygenic risk scores for ADHD in childhood tested on persistent ADHD as target sample. a Bar plot and b quintile plot of meta-analysis odds ratios (OR meta) with 95% confidence intervals for P value threshold = 0.4 using the third quintile as baseline.CC BY · PubMed Central
Fig. 3 Regional association plots for genome-wide significant loci identified in the GWAS meta-analysis of ADHD across the lifespan. Each plot includes information about the locus, the location and orientation of the genes in the region, the local estimates of recombination rate (in the right corner), and the LD estimates of surrounding SNPs with the index SNP (r2 values are estimated based on 1000 Genomes European reference panel), which is indicated by color (in the upper left corner).
Fig. 3 Regional association plots for genome-wide significant loci identified in the GWAS meta-analysis of ADHD across the lifespan. Each plot includes information about the locus, the location and orientation of the genes in the region, the local estimates of recombination rate (in the right corner), and the LD estimates of surrounding SNPs with the index SNP (r2 values are estimated based on 1000 Genomes European reference panel), which is indicated by color (in the upper left corner).CC BY · PubMed Central
Fig. 4 Genetic correlation of ADHD and several traits. a Dots represent genetic correlations (rg) for all traits considered (with h2 > 0.1 and z-score > 4) and those traits that met Bonferroni correction in both children and adult ADHD groups are presented in grey. r indicates Pearson’s correlation coefficient. b The ten strongest genetic correlations (with 95% confidence intervals) surpassing Bonferroni corrections in the children and persistent ADHD analysis are shown for each trait and ADHD.
Fig. 4 Genetic correlation of ADHD and several traits. a Dots represent genetic correlations (rg) for all traits considered (with h2 > 0.1 and z-score > 4) and those traits that met Bonferroni correction in both children and adult ADHD groups are presented in grey. r indicates Pearson’s correlation coefficient. b The ten strongest genetic correlations (with 95% confidence intervals) surpassing Bonferroni corrections in the children and persistent ADHD analysis are shown for each trait and ADHD.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Cited by

See all 119

Metadata

Authors
Rovira, P., Demontis, D., Sánchez-Mora, C., Zayats, T., Klein, M., Mota, N. R., Weber, H., Garcia-Martínez, I., Pagerols, M., Vilar-Ribó, L., Arribas, L., Richarte, V., Corrales, M., Fadeuilhe, C., Bosch, R., Martin, G. E., Almos, P., Doyle, A. E., Grevet, E. H., Grimm, O., Halmøy, A., Hoogman, M., Hutz, M., Jacob, C. P., Kittel-Schneider, S., Knappskog, P. M., Lundervold, A. J., Rivero, O., Rovaris, D. L., Salatino-Oliveira, A., da Silva, B. S., Svirin, E., Sprooten, E., Strekalova, T., ADHD Working Group of the Psychiatric Genomics Consortium, 23andMe Research team, Arias-Vasquez, A., Sonuga-Barke, E. J. S., Asherson, P., Bau, C. H. D., Buitelaar, J. K., Cormand, B., Faraone, S. V., Haavik, J., Johansson, S. E., Kuntsi, J., Larsson, H., Lesch, K.-P., Reif, A., Rohde, L. A., Casas, M., Børglum, A. D., Franke, B., Ramos-Quiroga, J. A., Soler Artigas, M., & Ribasés, M.
Affiliations
  • Universitat Autònoma de Barcelona (ES)
  • Aarhus University (DK)
  • Broad Institute (US)
  • Radboud University Nijmegen (NL)
  • University of Würzburg (DE)
  • Harvard University (US)
  • University Hospital Frankfurt (DE)
  • Haukeland University Hospital (NO)
  • Universidade Federal do Rio Grande do Sul (BR)
  • University of Bergen (NO)
  • Sechenov University (RU)
  • Radboud University Medical Center (NL)
  • King's College London (GB)
  • Centre for Biomedical Network Research on Rare Diseases (ES)
  • SUNY Upstate Medical University (US)
  • Örebro University (SE)
Corresponding author
Ribasés, Marta
Venue
Neuropsychopharmacology
Published
2020-04-12
Volume
45
Issue
10
Pages
1617-1626
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W3015807187
Cited by
111
References
75
Citations by year
2026: 9 · 2025: 12 · 2024: 15 · 2023: 20 · 2022: 15 · 2021: 23 · 2020: 16
FWCI
3.06
Type
journal article
Language
en
Open access
Licence
Locations
  • Neuropsychopharmacology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by)
  • SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Lume (Universidade Federal do Rio Grande do Sul) (submittedVersion, cc-by-nc-sa)
  • Monash University Research Portal (Monash University) (submittedVersion, other-oa)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • Eli Lilly and Company
  • Pfizer
  • American Academy of Child and Adolescent Psychiatry
  • Biogen
  • Aarhus Universitet
  • South London and Maudsley NHS Foundation Trust (278948)
  • Sunovion
  • GW Pharmaceuticals
  • National Institute for Health and Care Research (NF-SI-0616-10040, 10040, 278948, 14/23/17)
  • Department of Health and Social Care
  • King's College London (278948, NF-SI-0616-10040)
  • University of Oxford
  • European Commission (2014‐2020, H2020 Program, 643051, 2007–2013, Eat2beNICE, FP7 2007-2013, 278948, HORIZON2020, H2020, 728018, FP7/2007, H2020/2014-2020, 667302, 01EW1602B, 092330/31, 602805)
  • Deutsche Forschungsgemeinschaft (CRC TRR 58 A1, TRR‐58, 602805, CRC TRR 58 A1/A5, FP7/2007–2013, 44541416, Eat2beNICE, CRU 125, 91619115, 728018, 667302)
  • ZonMw (60-60600-97-193, 056-13-015, 60600, 433-09-242)
  • Radboud Universiteit
  • Vrije Universiteit Amsterdam (016-130-669, 433-09-242, FP7/2007-2013, 278948, 056-13-015)
  • Generalitat de Catalunya (SLT006/17/287, 2017SGR1461)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (400.17.602, 602805, 433‐09‐242, 175.010.2007.010, FP7 2007-2013, 05613015, 016‐130‐669, 728018, 278948, 60600, 667302, 91619115, 00023, 60-60600-97-193)
  • Accare
  • Ministerio de Economía y Competitividad (PI17/00289, PI16/, P19/01224, SAF2015-68341-R, PI16/01505, PI18/01788, PI19/00721)
  • Lundbeckfonden (R155-2014-1724, R102‐A9118, R248‐2017‐2003, R102-A9118 and R155-2014-1724)
  • Helse Vest
  • Shire
  • Vetenskapsrådet
  • Universitetet i Bergen
  • Universitair Medisch Centrum Groningen
  • Radboud Universitair Medisch Centrum
  • Vifor Pharma
  • Centro de Investigación Biomédica en Red de Salud Mental
  • European College of Neuropsychopharmacology
  • Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (H2020, SAF2015-68341-R, 2019-2020)
  • Servier
  • H. Lundbeck A/S (R102-A9118, R155-2014-1724)
  • National Institutes of Health (FP7/2007-2013, 2014-2020, 1750102007010, H2020)
  • Genentech
  • Horizon 2020 Framework Programme (H2020/2014–2020, 643051, FP7/2007-2013, 667302, 91619115, Eat2beNICE, 728018, R155-2014-1724, 01EW1902, 01EW1602B)
  • Stanley Center for Psychiatric Research, Broad Institute
  • Pfizer Pharmaceuticals
  • Medical Research Council (14/23/17)
  • Agència de Gestió d'Ajuts Universitaris i de Recerca (2017SGR1461, 2014-2020, 2017-SGR-738)
  • Instituto de Salud Carlos III (PI19/00721, PI16/, PI18/01788, CD15/00199, 00023, PI17/00289, SLT006/17/287, PI16/01505, P19/01224, 728018, 2014/2020, CP09/00119, Marató de TV3, CPII15/00023, H2020)
  • European Regional Development Fund (2014-2020’, H2020, 667302, 2007 – 2013, SLT006/17/287, 728018)
  • National Institute of Mental Health (U01MH109514, R01 MH 62873, U01MH109536, 016-130-669, R01MH101519, R01MH062873)
  • Cilag
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
Keywords
attention deficit hyperactivity disorder, childhood ADHD, genetic architecture, common genetic variants, genetic correlation, lifespan trajectories, neurodevelopmental disorders
MeSH terms
Genetic Background, Adult, Attention Deficit Disorder with Hyperactivity, Child, Humans, Impulsive Behavior, Phenotype, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Shared genetic background between children and adults with attention deficit/hyperactivity disorder. https://app.cochat.ai/papers/10.1038/s41386-020-0664-5
The paper
Rovira, P., Demontis, D., Sánchez-Mora, C., Zayats, T., Klein, M., Mota, N. R., Weber, H., Garcia-Martínez, I., Pagerols, M., Vilar-Ribó, L., Arribas, L., Richarte, V., Corrales, M., Fadeuilhe, C., Bosch, R., Martin, G. E., Almos, P., Doyle, A. E., Grevet, E. H., . . . Ribasés, M. (2020). Shared genetic background between children and adults with attention deficit/hyperactivity disorder. Neuropsychopharmacology. https://doi.org/10.1038/s41386-020-0664-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.